baber/WOPTO huggingface dataset:
Patent PT-1392613-E (PT)
Inventor: CONTE DOMINIQUE
IPC: G02B1/11
Filed: 2002-05-17
Abstract: A method that allows trimming glass comprising a hydrophobic and/or oil-repellent surface coating, where a temporary protective layer is coated on the surface of said glass and the temporary protective layer imparts to the glass a surface energy of at least 15 mJ/m2.
Patent PT-1461062-E (PT)
Title: Composition and method for treating chronic allograft rejection
Inventor: SALOMON DANIEL R
IPC: A61K38/13
Filed: 2002-12-05
Abstract: The invention provides a composition and a method for preventing or ameliorating the causes of chronic allograft rejection of a donor organ by a transplant recipient. The method includes concomitant administration to the allograft recipient of therapeutically effective amounts of cyclosporin and 2-chlorodeoxyadenosine. The composition comprises a combination of these two immunosuppressive drugs in therapeutically effective amounts suitable for the practice of the method.
Patent PT-1529116-E (PT)
Title: Method for predicting the responsiveness to treatment with rivastigmine based on the apoe genotyp of dementia patients
Inventor: LANE ROGER MICHAEL
IPC: G01N33/92
Filed: 2003-08-06
Abstract: This invention relates to methods to prevent worsening of and/or to improve cognitive functioning and behavior problems in patients with dementia by means of ApoE genotyping to guide the use of AChEI drugs, including rivastigimine. Also included are kits for determining ApoE4 status and recommended treatment strategy.
Patent PT-1668959-E (PT)
Title: Compatible multi-channel coding/decoding
Inventor: HERRE JUERGEN
IPC: H04S3/00
Filed: 2004-09-30
Abstract: In processing a multi-channel audio signal having at least three original channels, first and second downmix channels derived from the original channels are provided. For a selected original channel of the original channels, channel side information are calculated such that a downmix channel or a combined downmix channel including the first and second downmix channels, when weighted using the channel side information, results in an approximation of the selected original channel. The channel side information and the first and second downmix channels form output data to be transmitted to a low-level decoder, which only decodes the first and second downmix channels, or to a high-level decoder, which provides a full multi-channel audio signal based on the downmix channels and the channel side information. Since the channel side information occupy few bits only and since the decoder does not use dematrixing, an efficient and high quality multi-channel extension for stereo players and enhanced multi-channel players is acquired.
Patent PT-1571167-E (PT)
Title: Process for the preparation of rigid foams based on isocyanate
Inventor: HENSIEK RAINER
IPC: C08G18/10
Filed: 2005-02-18
Abstract: Production of isocyanate-based rigid foam by reacting polyisocyanates with compounds having at least 2 isocyanate-reactive hydrogen atoms, at least one of which is a polyester alcohol, comprises (A) reacting a polyester alcohol or a polyol mixture containing polyester alcohol(s) with less than the stoichiometric amount of at least difunctional isocyanate(s) to a prepolymer (I) containing urethane and hydroxyl groups, (B) reacting (I) with polyisocyanate. Independent claims are also included for the following: (1) (I) with a hydroxyl (OH) number in the 100-400 mg KOH/g range; (2) rigid isocyanate-based foams produced by this process.
Patent PT-1650002-E (PT)
Title: Hot runner nozzle
Inventor: SPULLER SWEN
IPC: B29C48/96
Filed: 2005-10-01
Abstract: The area of the mass channel is limited around the inlet opening (6) for preventing the melt flow and extends in the direction of the nozzle outlet (5). The socket (7) has parallel running recesses (9), which forms threads in the walls of the mass channel (4). The cross section of the recesses is increased with increasing distance of the inlet.
Patent PT-2024278-E (PT)
Title: Method for the coupled production of chlorine and isocyanates
Inventor: KAEMPER FRIEDHELM
IPC: C01B32/80
Filed: 2007-05-03
Abstract: A process for the coupled production of chlorine and isocyanates in which the sulfuric acid used for both processes is combined after use, concentrated together and returned to one or both processes.
Patent PT-736004-E (PT)
Inventor: CARNEY JOHN M
IPC: A61P35/00
Filed: 1994-12-22
Abstract: 2,4-disulfonyl  alpha -phenyl-tert-butyl nitrone and its pharmaceutically acceptable salts are disclosed. These materials are useful as pharmaceutical agents for oral or intravenous administration to patients suffering from acute central nervous system oxidation as occurs in a stroke or from gradual central nervous system oxidation which can exhibit itself as progressive central nervous system function loss.
Patent PT-770077-E (PT)
Inventor: DVORAK CHARLES ALOIS
IPC: C07D453/02
Filed: 1995-07-01
Abstract: This invention relates to processes for preparing 2-(1-azabicyclo[2.2.2]oct-3-yl)-2,3,3a,4,5,6-tetrahydro-1H-benz[de]isoquinolin-1-one, particularly 2-(1-azabicyclo[2.2.2]oct-3S-yl)-2, 3,3aS,4,5,6-tetrahydro-1H-benz[de]isoquinolin-1-one, and to intermediates useful in such processes.
Patent PT-777739-E (PT)
Inventor: SEDLACEK HANS-HARALD
IPC: C12R1/91
Filed: 1995-08-25
Abstract: PCT No. PCT/EP95/03370 Sec. 371 Date Apr. 18, 1997 Sec. 102(e) Date Apr. 18, 1997 PCT Filed Aug. 25, 1995 PCT Pub. No. WO96/06940 PCT Pub. Date Mar. 7, 1996A DNA sequence for the gene therapy of tumors is described. In its essential elements, the DNA sequence is composed of an activator sequence, a promoter module and a gene for the active substance. The activator sequence is activated, in a cell-specific manner, in proliferating endothelial cells or in cells which are adjacent to these endothelial cells. This activation is regulated by the promoter module in a cell cycle-specific manner. The active substance is an inhibitor of angiogenesis or a cytostatic or cytotoxic molecule. The DNA sequence is inserted into a viral or non-viral vector which is supplemented with a ligand which possesses affinity for the activated endothelial cell.
Patent PT-784518-E (PT)
Inventor: MCCLURE JAMES C
IPC: B01L99/00
Filed: 1995-09-29
Abstract: An apparatus includes a first mechanical component for cleaning parts by contacting the parts with a fluid, and a second mechanical component for biodegrading the organic matter removed from the parts. The first mechanical component is in communication with the second mechanical component so that the fluid recirculates between the first and second mechanical components. A method of washing parts including the steps of placing an article in a first chamber (20), circulating a washing liquid (82) from a second reservoir (80) to the first reservoir (20) to wash the surfaces of the article in contact with the liquid, passing the washing liquid (82) through a porous medium (38), draining the washing liquid from the first chamber (20) into the second chamber (80), removing organic matter in the washing liquid (82) and recirculating the washing liquid from the second chamber (80) to the first chamber (20), is also provided. <IMAGE>
Patent PT-787002-E (PT)
Title: Competitive progesterone antagonists for regulating female fertility as required
Inventor: CHWALISZ KRISTOF
IPC: A61K31/58
Filed: 1995-10-24
Abstract: This invention describes the novel use of dissociated competitive progesterone antagonists for the production of a pharmaceutical agent for demand-oriented female birth control (pill on demand), which can be used regardless of the point in the menstrual cycle, in a dosage unit that is to be administered on a one-time basis, whose dosage is below the ovulation-inhibiting dosage.
Patent PT-767279-E (PT)
Inventor: SODERGARD BENGT
IPC: F04D29/62
Filed: 1996-09-25
Abstract: The pumping station (1) with sewage inlet (4) comprises a vertical circular shaft (2) steeply sloped (16) at the bottom to a narrow sump (3) which is wide enough to accommodate two side by side submersible pumps (6) with inlets (7). Each pump is mounted by a pivoting bracket (9) on a guide (14) for lifting and maintenance. The pump outlet flange (8) is sealed against a connection unit (1) by a wedging lug on the bracket (9). The unit (13) is mounted on the sloping side (16) and connected to the discharge pipe(5). All projecting surfaces are steeply sloped and faired to eliminate trapping of sludge or larger material.
Patent PT-835849-E (PT)
Inventor: GLAUBITT WALTHER
IPC: G02B1/113
Filed: 1997-09-20
Abstract: A process for the production of a porous anti-reflection coating comprises applying a colloidal-disperse solution (CS) to a substrate, drying the coating and removing organic components by heating. Solution CS is obtained by hydrolytic condensation of silicon compound(s) of formula RaSiX4-a (I) and/or precondensates derived from (I), in which R = 1-10C organic residue, optionally with in-chain oxygen and/or sulphur and/or amino groups; X = H, halogen, hydroxy, alkoxy, acyloxy alkylcarbonyl, alkoxycarbonyl or N(R<1>)2 (with R<1> = H, alkyl or aryl); a = 0, 1 or 2. Hydrolysis/condensation is carried out by the action of water or moisture, optionally in presence of solvent and/or catalyst, and solution CS also contains organic polymer(s) with OH and/or NH groups and an average mol. wt. of 200-500,000 (II), in a mol. ratio of 0.1-100 mmols (II)/mol silane. Also claimed are: (i) an anti-reflection made by this process, and (ii) a coating solution (CS) as above.
Patent PT-896600-E (PT)
Inventor: LUTHRA AJAY KUMAR
IPC: C08F220/54
Filed: 1997-04-30
Abstract: PCT No. PCT/GB97/01173 Sec. 371 Date Apr. 30, 1999 Sec. 102(e) Date Apr. 30, 1999 PCT Filed Apr. 30, 1997 PCT Pub. No. WO97/41164 PCT Pub. Date Nov. 6, 1997Polymers having non-thrombogenic properties can be prepared by copolymerizing monomers of at least three classes selected from (a) monomers having sulphate groups, (b) monomers having sulphonate groups, (c) monomers having sulphamate groups, (d) monomers having polyoxyalkylene ether groups, and (e) monomers having zwitterionic groups. The polymers can additionally be provided with anti-thrombogenic properties by including an additional comonomer having a pendant heparin (or hirudin, warfarin or hyaluronic acid) group. The polymers can be used as coating materials for medical devices, such as tubing or connectors, in order to provide them with non-thrombogenic, and optionally anti-thrombogenic, properties.
Patent PT-1014943-E (PT)
Inventor: MANFRED KELLER DR
IPC: A61K31/00
Filed: 1998-02-02
Abstract: A pressure-liquefied propellant mixture for aerosols, comprising a fluorinated alkane, in particular 1,1,1,2-tetrafluoroethane and/or 1,1,1,2,3,3,3-heptafluoropropane, and carbon dioxide, makes possible an improvement of the wetting properties of pharmaceutically active compounds, with which the formulation problems existing with hydrofluoroalkanes in relation to suspension as well as solution aerosols can be overcome and thus improved medicinal aerosol formulations can be obtained. With the aid of carbon dioxide, it is also possible to specifically influence the pressure and thus the particle size distribution and also by displacement of oxygen from the hydrofluoroalkanes to improve the storage stability of oxidation-sensitive active compounds.
Patent PT-987126-E (PT)
Inventor: SMITH ROBERT WILLIAM
IPC: B41M3/12
Filed: 1999-09-16
Abstract: A method of producing a direct application transfer, whereby a covercoat is formed on a release paper, and a digitally printed design is formed on the covercoat. The transfer can be applied to a ceramic or glass substrate with heat and/or pressure being applied thereto such that the covercoat and design locate on the substrate and can be freed from the release paper.
Patent PT-1102980-E (PT)
Inventor: OTTMAR HERBERT
IPC: G01N23/22
Filed: 1999-07-28
Abstract: A sample changer for transferring radioactive samples between a hot cell (12) and a measuring apparatus (10), as e.g. a hybrid K-edge densitometer, comprises a transfer channel (28) axially extending through a tubular containment (22) between the charging/discharging port and the measuring window section D. A recipient (24), with at least one compartment (100) for receiving therein a radioactive sample, is arranged in the transfer channel (28) so as to be movable therethrough. A threaded spindle (44) is rotatably housed in a spindle channel (42) below the transfer channel (28). A coupling (46) passing in a sealed manner through the closed rear end section connects a stepping motor (34) to the threaded spindle (44). A longitudinally guided support carriage supports the magazine (24) and engages the threaded spindle (44), so as to be subjected to a translational movement upon rotation of the spindle (44).
Patent SG-2993-G (SG)
Title: An arrangement for the sterilizing of a travelling material web
IPC: B65B55/10
Filed: 1993-01-06
Abstract: An arrangement for the sterilization of a travelling material web (1) which omprises a chamber (10) with inlet (11) and outlet (12) for the web and also inlet and outlet openings (16 and 19 respectively) for the sterilizing gas flow. The chamber comprises constriction zones (10a and 10b) arranged between the inlet (11) and the outlet (12) which are connected to one another by an intermediate chamber portion (10c) and are designed so that the web can only just pass freely. The intermediate portion (10c) is in connection with a gas source through an opening (16) whilst the constriction zones (10a and 10b) are connected to a vacuum source (18) through one or more outlet openings (19).
Patent SG-26361-G (SG)
Title: Recording and/or reproducing apparatus for flexible magnetic disks
Inventor: MASAKI HIROSHI
IPC: G11B17/043
Filed: 1986-10-02
Abstract: The invention is concerned with a recording and/or reproducing apparatus for a flexible magnetic disk, which includes a cassette holder (19) in which there is inserted and held a cassette accommodating a magnetic disk, a rotational driving device for driving the magnetic disk, elements (32,34) for raising and lowering the holder (19) relative to the driving device, and a head unit (71) having a pair of movable arms (74,77) with magnetic heads (75,76) slidably contacting the upper and lower sides of the magnetic disk. One of the supporting arms (74,77) is turned in operative associated with the up or down movement of the cassette holder (19) so that the magnetic heads (75,76) are brought into or out of contact with the magnetic disk. Thanks to the elements (32,34), the holder (19) in which the disk cassette is inserted is lowered with a delay at the side thereof towards the head unit (71) relative to the side thereof that the disk cassette is introduced, in order that the magnetic disk is clamped by the magnetic heads (75,76) after the chucking of the magnetic disk in the driving device is terminated.
Patent IE-44415-L (IE)
Title: Container for consumables
IPC: B65D85/50
Filed: 1977-01-18
Abstract: The packing box is made from plastic material and consists of a box and a tight fitting lid. The box is rectangular and has a base which is raised in its central portion. The base is covered in rows of rectangular pyramids (22) which are evenly spaced across the base. The inner edges of the container are provided with wedges (20), having the same angles as the pyramids. The sausages are laid in rows in between the pyramids and so cannot move and do not touch one another. The box is shallow so that only one row of sausages is packed. A tight fitting lid closes the packing with the lip (7).
[FR2343668A1]
Patent IE-780127-L (IE)
Title: Thiazoloindole derivatives.
IPC: C07D209/12
Filed: 1978-01-20
Abstract: Compounds of the formula: <IMAGE> wherein A represents a heterocyclic radical selected from 3-pyridyl, 4-pyridyl, 5-isoquinolyl and 5-isoquinolyl substituted in the 3-position by an alkyl radical containing 1 to 10 carbon atoms, are new compounds possessing pharmacological properties, in particular analgesic, antipyretic and anti-inflammatory properties.
[US4153699A]
Patent IE-43761-L (IE)
Title: Astigmatic focus correction
IPC: H04N3/233
Filed: 1976-01-26
Abstract: A cathode ray tube employing magnetic deflection coils for deflecting the electron beam in the horizontal and vertical directions, is corrected for the astigmatism error created by the non-uniform magnetic deflection field which causes a predictable elliptical distortion of the electron beam, through the use of two sets of correction coils mounted on a common annular magnetic core located on the neck of the CRT, which distorts the electron beam prior to its entry into the magnetic deflection field in a manner that is complementary to the distortion created by the non-uniform magnetic deflection field. The excitation currents for the correction coils are derived from the horizontal (Vx) and vertical (Vy) beam deflection voltage signals, in such a manner that the excitation current for the first correction coil is proportional to Vx2 - Vy2, and the excitation for the second correction coil is proportional to 2.Vx.Vy.
[US3961223A]
Patent IE-890237-L (IE)
Title: Conjugates of antibodies and vinca drugs
IPC: C07K16/00
Filed: 1989-01-26
Abstract: Immunoglobulin conjugates are formed by reaction of an antineoplastic indole-dihydroindole vinca alkaloid containing a hydrazide group attached at C-3 or C-4 with an oxidized IgG antibody having unusually high carbohydrate content, and are of the formula <CHEM> wherein R<2> is H, CH3 or CHO; when R<4> and R<5> are taken singly, R<5> is H, and one of R<3> and R<4> is ethyl and the other is H or OH; when R<4> and R<5> are taken together with the carbons to which they are attached, they form an oxirane ring in which case R<3> is ethyl; R is NHN=, <CHEM> O(C1-3 alkyl), NH2, NH(C1-3 alkyl), NH-CH2CH2-Y, 1-pyrrolidinyl or 1-piperidinyl, wherein n is 2-4 and Y is Cl, OCH3 or SCH3; R<1> is H, (C1-3 alkyl)-CO, chloro-substituted (C1-3 alkyl)-CO or R<6> wherein R<6> is COXCONHN= wherein X is C1-4 straight chain alkylene, C2-8 branched chain alkylene, C2-4 alkenylene, C3-4 alkenylene, C3-6 cycloalkylene, phenylene, hydroxy-substituted C1-4 alkylene, or a direct bond, provided that either R is NHN= or R<1> is R<6>, but R cannot be NHN= when R<1> is R<6> and R<1> cannot be R<6> when R is NHN=; m is an integer from about 5 to about 35; Ab is an antibody of the IgG class, containing from about 6% to about 18% of carbohydrate.
[EP0326322A1]
Patent IE-800268-L (IE)
Title: Improved method for chlorinating the carboxylic group of¹2-(p-hydroxyphenyl) glycine
IPC: C07C51/60
Filed: 1980-02-12
Abstract: A method for chlorinating the carboxylic group of alpha -aminoacids (e.g. hydroxyphenyl-glycine) is described wherein the aminoacid is suspended in an optionally solvate-forming solvent, treated with an excess of gaseous HCl and then with a chlorinating agent having the general formula [SOaCl2.R1R2NCHO] (e.g. SO Cl2.(CH3)2NCHO). A typical compound thus obtained is the dioxane hemisolvate of D(-)2-(p-hydroxyphenyl)glycyl chloride hydrochloride.
[US4369146A]
Patent IE-800337-L (IE)
Title: Pyrimidone derivatives
IPC: A61K31/505
Filed: 1980-02-20
Abstract: Pyrimidone derivatives, which have histamine H2-antagonist activity, of structure <CHEM> in which R is hydrogen, alkyl, alkanoyl or aroyl, X is hydrogen, chlorine, bromine or alkyl; Y is sulphur or methylene, n is 2 or 3, Z is hydrogen or lower alkyl, A is alkylene or -(CH2)pW(CH2)q - where W is oxygen or sulphur and p and q are such that their sum is from 1 to 4; B is hydrogen, methyl, cycloalkyl, or an optionally substituted phenyl or heteroaryl group 
[EP0015138A1]
Patent IE-35174-L (IE)
Title: Drill bit.
IPC: B23B51/00
Filed: 1971-04-28
Abstract: For obtaining the maximum effectiveness from an axially extending drill with a hard metallic insert positioned on its drill end and a pair of axially extending oppositely spaced surfaces formed in its cylindrically shaped shaft, the ratio of the maximum diameter of its shaft to the dimension between the oppositely disposed surfaces is in the range of 1 : 0.7 to 1 : 0.8.
[US3711217A]
Patent IE-35220-L (IE)
Title: Imidazole derivatives
IPC: C07D213/77
Filed: 1971-05-12
Abstract: 1342713 Azo compounds ALLEN & HANBURYS Ltd 12 May 1971 [3 June 1970] 26812/70 Heading C2C Novel compounds of Formula I (in which each of R<SP>1</SP>, R<SP>2</SP>, R<SP>3</SP> and R<SP>4</SP> is C 1-6 alkyl, C 2-6 alkenyl, halogen, aralkyl or aryl optionally substituted by hydroxy, alkoxy, halogen, nitro or trifluoromethyl, and R<SP>1</SP> and R<SP>2</SP> may also be hydrogen, and any two adjacent R groups together with the two atoms of the imidazole ring, may form a 5, 6 or 7 membered carbocyclic or heterocyclic ring, and X is a physiologically acceptable anion) are prepared by oxidation of compounds of the Formula II for example by means of chlorine or bromine, followed by optional conversion of an atom or group R<SP>1</SP> e -R<SP>4</SP> into another such atom or group. Compounds of the Formula II are generally prepared via acetyl-hydrazine intermediates according to the following reaction scheme 1 - Amino - 3 - methyl - 2,5 - diphenylimidazolium iodide is prepared by reacting 1-amino-2,5- diphenylimidazole (itself prepared by reacting ethyl benzimidate with 2-acetylhydrazine to form 1 - acetyl - 2 - benzimidoyl - hydrazine, reacting this with phenacyl bromide to form 1 - acetylamino - 2,5 - diphenylimidazole and hydrolysing this compound) with methyl iodide. The bromide and picrate salts are prepared from the iodide salt. 1 - Amino - 3 - methyl - 2 - phenylimidazo[1,2-a]pyridinium bromide and 1- amino - 2,3 - dimethylbenzimidazolium bromide are prepared by hydrolysis of the corresponding 1 - acetylamino compounds. 1 - Amino - 3- bromo - 2 - phenylimidazo[1,2-a]pyridinium bromide is prepared by bromination of 1- amino - 2 - phenylimidazo[1,2-a]pyridinium bromide. 1 - Amino - 5,6,7,8 - tetrahydro - 2- phenyl - imidazo[1,2-a]pyridiniuin bromide is prepared by hydrogenation of 1-amino-2- phenylimidazo[1,2-a]pyridinium bromide. 1 - Acetamido - 3 - methyl - 2 - phenyl - imidazo[1,2-a]pyridinium bromide is prepared by reacting 2 - (2 - acetylhydrazino)pyridine with 2 - bromopropiophenone. 1 - Acetamido - 2,3- dimethylbenzimidazolium iodide is prepared by reacting 1 - acetamido - 2 - methylbenzimidazole with methyl iodide. 2 - (2 - Acetylhydrazino)pyridine is prepared by reacting 2-hydrazinopyridine with acetic anhydride. 5,6,7,8 - Tetrahydro - 2 - phenylimidazo- [1,2-a]pyridine hydrobromide is prepared by thermal decomposition of 1,1<SP>1</SP>-azobis-[5,6,7,8- tetrahydro - 2 - phenyl - 1H - imidazo[1,2-a]- pyridinum] dibromide. Pharmaceutical compositions having neuromuscular blocking activity, comprise a compound of Formula I together with a pharmaceutically acceptable carrier. The compositions may be administered parenterally.
[GB1342713A]
Patent IE-820776-L (IE)
Title: Radiolabelled peptides for locating thrombi
IPC: A61K38/17
Filed: 1982-04-01
Abstract: Thrombi are located in vivo by administering a radiolabelled peptide selected from Fragment E1 isolated from cross-linked fibrin, Fragment E2 isolated from cross-linked fibrin, and peptides having an amino acid sequence intermediate between Fragments E1 and E2 derived from cross-linked fibrin to a human or animal and externally detecting the radiation emitted by the radiolabelled peptide.
Patent IE-890951-L (IE)
Title: Fluid container
IPC: A61J1/05
Filed: 1989-03-23
Abstract: A fluid container comprising a flexible bag (1) containing a diluent and having a closing film at its upper end, a capsule (2) connected to the flexible bag, a drug container (3) held in the capsule and a communicating means (16) communicating the flexible bag with the drug container. The communicating means has a double-edged hollow needle (7) having a hub in the midway thereof, and a controlling means (6) for controlling the order of communication in such a manner that the plug of the drug container is sticked with one edge of the needle and thereafter the closing film of the flexible bag is sticked with the other end of the needle. The mixing procedure is sure and simple, and can be carried out in a short time.
[EP0335378A2]